Back to Awarded Treatment Trials


Awarded Trial: 14T-007

Grant ID

14T-007

Illness

Schizophrenia

Primary Drug/Intervention

Garcinia mangostana Linn (mangosteen) pericarp

Primary Dosage

1000 mg daily

Secondary Drug Intervention

antipsychotic drug treatment

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Berk

Sample Size

150

Duration of Study Period for Each Subject

168 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Michael Berk

Degree

MD, PhD

Center

School of Medicine

Institution

Deakin University

Address

PO Box 281

City or Town

Geelong

State or Province

VIC

Zip or Postal Code

3220

Country

Australia

Email Address

mikebe@barwonhealth.org.au